147 related articles for article (PubMed ID: 9363862)
1. Phase I trial and pharmacokinetic study of all-trans-retinoic acid administered on an intermittent schedule in combination with interferon-alpha2a in pediatric patients with refractory cancer.
Adamson PC; Reaman G; Finklestein JZ; Feusner J; Berg SL; Blaney SM; O'Brien M; Murphy RF; Balis FM
J Clin Oncol; 1997 Nov; 15(11):3330-7. PubMed ID: 9363862
[TBL] [Abstract][Full Text] [Related]
2. A phase 2 trial of all-trans-retinoic acid in combination with interferon-alpha2a in children with recurrent neuroblastoma or Wilms tumor: A Pediatric Oncology Branch, NCI and Children's Oncology Group Study.
Adamson PC; Matthay KK; O'Brien M; Reaman GH; Sato JK; Balis FM
Pediatr Blood Cancer; 2007 Oct; 49(5):661-5. PubMed ID: 16900483
[TBL] [Abstract][Full Text] [Related]
3. A phase I trial and pharmacokinetic study of 9-cis-retinoic acid (ALRT1057) in pediatric patients with refractory cancer: a joint Pediatric Oncology Branch, National Cancer Institute, and Children's Cancer Group study.
Adamson PC; Widemann BC; Reaman GH; Seibel NL; Murphy RF; Gillespie AF; Balis FM
Clin Cancer Res; 2001 Oct; 7(10):3034-9. PubMed ID: 11595692
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of all-trans-retinoic acid administered on an intermittent schedule.
Adamson PC; Bailey J; Pluda J; Poplack DG; Bauza S; Murphy RF; Yarchoan R; Balis FM
J Clin Oncol; 1995 May; 13(5):1238-41. PubMed ID: 7738627
[TBL] [Abstract][Full Text] [Related]
5. Phase I/II study of intermittent all-trans-retinoic acid, alone and in combination with interferon alfa-2a, in patients with epidemic Kaposi's sarcoma.
Bailey J; Pluda JM; Foli A; Saville MW; Bauza S; Adamson PC; Murphy RF; Cohen RB; Broder S; Yarchoan R
J Clin Oncol; 1995 Aug; 13(8):1966-74. PubMed ID: 7636537
[TBL] [Abstract][Full Text] [Related]
6. All-trans retinoic acid and interferon-alpha-2a in patients with metastatic or recurrent carcinoma of the uterine cervix: clinical and pharmacokinetic studies. New York Gynecologic Oncology Group.
Wadler S; Schwartz EL; Haynes H; Rameau R; Quish A; Mandeli J; Gallagher R; Hallam S; Fields A; Goldberg G; McGill F; Jennings S; Wallach RC; Runowicz CD
Cancer; 1997 Apr; 79(8):1574-80. PubMed ID: 9118041
[TBL] [Abstract][Full Text] [Related]
7. Biological activity of all-trans-retinoic acid with and without tamoxifen and alpha-interferon 2a in breast cancer patients.
Toma S; Raffo P; Nicolo G; Canavese G; Margallo E; Vecchio C; Dastoli G; Iacona I; Regazzi-Bonora M
Int J Oncol; 2000 Nov; 17(5):991-1000. PubMed ID: 11029503
[TBL] [Abstract][Full Text] [Related]
8. Phase 1/2 clinical trial of interferon alpha2b and weekly liposome-encapsulated all-trans retinoic acid in patients with advanced renal cell carcinoma.
Boorjian SA; Milowsky MI; Kaplan J; Albert M; Cobham MV; Coll DM; Mongan NP; Shelton G; Petrylak D; Gudas LJ; Nanus DM
J Immunother; 2007 Sep; 30(6):655-62. PubMed ID: 17667529
[TBL] [Abstract][Full Text] [Related]
9. Unexpected high incidence of severe toxicities associated with alpha interferon, low-dose cytosine arabinoside and all-trans retinoic acid in patients with chronic myelogenous leukemia.
Sacchi S; Kantarjian HM; Freireich EJ; O'Brien S; Cortes J; Rios MB; Kornblau S; Giles FJ; Koller C; Gajewski J; Talpaz M
Leuk Lymphoma; 1999 Nov; 35(5-6):483-9. PubMed ID: 10609785
[TBL] [Abstract][Full Text] [Related]
10. Phase I trial of interferon alpha2b and liposome-encapsulated all-trans retinoic acid in the treatment of patients with advanced renal cell carcinoma.
Goldberg JS; Vargas M; Rosmarin AS; Milowsky MI; Papanicoloau N; Gudas LJ; Shelton G; Feit K; Petrylak D; Nanus DM
Cancer; 2002 Sep; 95(6):1220-7. PubMed ID: 12216088
[TBL] [Abstract][Full Text] [Related]
11. Clinical and pharmacokinetic studies of all-trans-retinoic acid in pediatric patients with cancer.
Adamson PC
Leukemia; 1994; 8 Suppl 3():S22-5. PubMed ID: 7808020
[TBL] [Abstract][Full Text] [Related]
12. Phase I clinical trial of all-trans-retinoic acid with correlation of its pharmacokinetics and pharmacodynamics.
Conley BA; Egorin MJ; Sridhara R; Finley R; Hemady R; Wu S; Tait NS; Van Echo DA
Cancer Chemother Pharmacol; 1997; 39(4):291-9. PubMed ID: 9025769
[TBL] [Abstract][Full Text] [Related]
13. Clinical and pharmacokinetic studies of all-trans-retinoic acid in pediatric patients with cancer.
Adamson PC
Leukemia; 1994 Nov; 8(11):1813-6. PubMed ID: 7967727
[TBL] [Abstract][Full Text] [Related]
14. All-trans retinoic acid (ATRA) in patients with chronic myeloid leukemia in the chronic phase.
Russo D; Regazzi M; Sacchi S; Visani G; Lazzarino M; Avvisati G; Pelicci PG; Dastoli G; Grandi C; Iacona I; Candoni A; Grattoni R; Galieni P; Rupoli S; Liberati AM; Maiolo AT
Leukemia; 1998 Apr; 12(4):449-54. PubMed ID: 9557600
[TBL] [Abstract][Full Text] [Related]
15. A phase I study of recombinant human interleukin-2 and alpha-interferon-2a in patients with renal cell cancer, colorectal cancer, and malignant melanoma.
Mittelman A; Huberman M; Puccio C; Fallon B; Tessitore J; Savona S; Eyre R; Gafney E; Wick M; Skelos A
Cancer; 1990 Aug; 66(4):664-9. PubMed ID: 2386896
[TBL] [Abstract][Full Text] [Related]
16. Clinical trial of weekly intensive therapy with 5-fluorouracil on two different schedules combined with interferon alpha-2a and filgrastim in patients with advanced solid tumors: Eastern Cooperative Oncology Group Study P-Z991.
Wadler S; Atkins M; Karp D; Neuberg D; Haynes H; Dutcher JP
Cancer J Sci Am; 1998; 4(4):261-8. PubMed ID: 9689985
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacokinetic studies of all-trans retinoic acid (ATRA) and pilot study of intermittent schedule of ATRA and chemotherapy in childhood acute promyelocytic leukemia. Children's Cancer and Leukemia Study Group].
Hirota T; Fujimoto T; Konno K; Sakakibara Y; Katano N; Tsurusawa M; Takitani K; Miyake M
Rinsho Ketsueki; 1997 Nov; 38(11):1170-6. PubMed ID: 9423333
[TBL] [Abstract][Full Text] [Related]
18. Alterations in tretinoin pharmacokinetics following administration of liposomal all-trans retinoic acid.
Estey E; Thall PF; Mehta K; Rosenblum M; Brewer T; Simmons V; Cabanillas F; Kurzrock R; Lopez-Berestein G
Blood; 1996 May; 87(9):3650-4. PubMed ID: 8611689
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of all-trans retinoic acid in the accelerated phase or early blastic phase of chronic myeloid leukemia: a study of the Eastern Cooperative Oncology Group (E1993).
Dutcher JP; Lee S; Gallagher RE; Makary AZ; Hines JD; Londer H; Farnen JP; Bennett JM; Paietta E; Rowe JM; Goloubeva O; Wiernik PH;
Leuk Lymphoma; 2005 Mar; 46(3):377-85. PubMed ID: 15621827
[TBL] [Abstract][Full Text] [Related]
20. Phase I-II study of 5-fluorouracil, recombinant interferon alpha2a, and cisplatin in combination with external beam radiation therapy followed by surgery in patients with locally advanced carcinoma of the esophagus.
Damle S; Beitler JJ; Haynes H; Camacho M; Wolf E; Wadler S
Am J Clin Oncol; 1999 Aug; 22(4):391-5. PubMed ID: 10440197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
